Net Medical Xpress Solutions, Inc.

As of June 30, 2018, Net Medical Xpress Solutions, Inc. carries a market capitalization of 996,281.64, placing it among publicly traded companies globally. Its enterprise value stands at 787,281.64, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2018, Net Medical Xpress Solutions, Inc. has 19.89M shares outstanding.

These figures are as of June 30, 2018. The price-to-sales ratio is 0.42, and the price-to-book ratio stands at 2.44.

These figures are as of June 30, 2018. The EV/Sales ratio of 0.34 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 787,281.64 versus a market cap of 996,281.64, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2018, Net Medical Xpress Solutions, Inc. maintains a current ratio of 1.58, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.63, indicating elevated leverage, while an interest coverage ratio of -15.36 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2018, Net Medical Xpress Solutions, Inc. posted a negative return on equity (ROE) of -50.21, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -21.99, reflecting losses generated across the asset base. The company generates approximately 101,478.26 in revenue per employee across its workforce of 23.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 112.65 indicates how many times Net Medical Xpress Solutions, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on July 23, 2026, Net Medical Xpress Solutions, Inc.'s stock has gained approximately 601.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.02.

Over the twelve months ended June 30, 2018, Net Medical Xpress Solutions, Inc. generated 2.33M in revenue and converted that into -182,000.00 in net income, yielding earnings per share of -0.01. EBITDA reached -169,000.00, while operating income came in at -171,000.00.

As of June 30, 2018, Net Medical Xpress Solutions, Inc. holds 277,000.00 in cash and equivalents against 68,000.00 in total debt, resulting in a net debt position of -214,000.00. Total book value stands at 409,000.00, with working capital of 236,000.00 providing operational flexibility.

Net Medical Xpress Solutions, Inc. produced -122,000.00 in operating cash flow over the twelve months ended June 30, 2018. After subtracting - - in capital expenditures, free cash flow totaled -122,000.00 - equivalent to -0.01 per share.

Over the twelve months ended June 30, 2018, Net Medical Xpress Solutions, Inc. posted a gross margin of 25.19, reflecting its pricing power and cost economics. The operating margin of -7.33 and net profit margin of -7.80 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2018. Free cash flow yield is negative at -12.38: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -10.34, meaning Net Medical Xpress Solutions, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Net Medical Xpress Solutions, Inc.'s most recent stock split took place on June 20, 2016 with a 9:1 split ratio.

As of June 30, 2018, Net Medical Xpress Solutions, Inc. has an Altman Z-Score of -29.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.